Market News

BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

0

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.

Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

Austria re-imposes a full Covid lockdown and makes vaccination mandatory

Previous article

Insider buying: Leaders at Uber, Arch Capital bought millions in their own stock this week

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Market News